Human IgG (H&L) Antibody
Applications | WB: 1:5,000 - 1:20,000 IHC: 1:1,000 - 1:5,000 ELISA: 1:30,000 - 1:60,000 |
Conjugation | Unconjugated |
Human IgG (H&L) Antibody
Applications | WB: 1:5,000 - 1:20,000 IHC: 1:1,000 - 1:5,000 ELISA: 1:30,000 - 1:60,000 |
Conjugation | Unconjugated |
Human IgG (H&L) Antibody Alkaline Phosphatase Conjugated
Applications | WB: 1:500 - 1:2,500 IHC: 1:200 - 1:1,000 ELISA: 1:2,000 - 1:10,000 |
Reactivities | Human |
Conjugation | Alkaline Phosphatase |
Rat IgG (H&L) Antibody
Applications | WB: 1:2,000 - 1:10,000 IHC: 1:1,000 - 1:5,000 ELISA: 1:20,000 - 1:100,000 |
Conjugation | Unconjugated |
2-Amino Benzimidazole Sulphone sheep polyclonal antibody, Ig Fraction
Applications | ELISA |
Eph receptor B1 (EPHB1) (Cytopl. Dom.) sheep polyclonal antibody, Purified
Applications | IP |
Reactivities | Human |
FCY1 sheep polyclonal antibody, Ig Fraction
Applications | ELISA, WB |
Reactivities | Yeast |
Alpha 1 microglobulin (AMBP) sheep polyclonal antibody, Purified
Applications | ELISA, ID |
Reactivities | Human |
Sheep Anti-Dynamin (Ser778) Antibody (Phospho-Specific)
Applications | WB |
Reactivities | Rat |
Modifications | Phospho-specific |
Sheep Anti-Dopamine β-Hydroxylase, N-Terminus, Human Antibody
Applications | WB |
Reactivities | Human, Primate |
Sheep Anti-Vesicular Monoamine Transporter 2, C-terminus (VMAT2) Antibody
Applications | WB |
Reactivities | Rat |
Sheep Anti-Calretinin Antibody
Applications | WB |
Reactivities | Rat |
Sheep Anti-Dynamin (Ser774) Antibody (Phospho-Specific)
Applications | WB |
Reactivities | Rat |
Modifications | Phospho-specific |
Sheep Anti-Tryptophan Hydroxylase Antibody
Applications | WB |
Reactivities | Human, Rat |
Bovine IgG1 sheep polyclonal antibody, Aff - Purified
Applications | ELISA. Immunodiffusion. |
Reactivities | Bovine |
Conjugation | Unconjugated |
Human IgA (Fc specific) sheep polyclonal antibody, TRITC
Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of IgA. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/10-1/40 This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
Reactivities | Human |
Conjugation | TRITC |